Matias Autio

1.2k citations
19 papers · 328 indexed · h-index 8
Topics
Lymphoma Diagnosis and Treatment (10 papers)CAR-T cell therapy research (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)
Partner nations
FinlandDenmarkNorway

In The Last Decade

Matias Autio

17 papers receiving 326 citations

Peers

Matias Autio
Comparison fields: 5 of 39
  • Pathology and Forensic Medicine 180
  • Oncology 157
  • Molecular Biology 112
  • Immunology 91
  • Cancer Research 70
Replace Lorena Barclay with:
Lorena Barclay Canada
Katrin Bertram Switzerland
Jessica Lam United States
Ines Pfeil Germany
Sarah Péricart France
Hilka Rauert‐Wunderlich Germany
Kerstin Dietze Germany
David A. Delgado United States
Hannelore Madle Germany
María-Jesús Artiga Spain
Matias Autio relative to Lorena Barclay Canada Lorena Barclay's profile →
Citations per field
00.5×10×15×19.3×
Lorena Barclay · 1×
Citations per year

Countries citing papers authored by Matias Autio

Since Specialization
Citations

This map shows the geographic impact of Matias Autio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matias Autio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matias Autio more than expected).

Fields of papers citing papers by Matias Autio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matias Autio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matias Autio. The network helps show where Matias Autio may publish in the future.

Co-authorship network of co-authors of Matias Autio

This figure shows the co-authorship network connecting the top 25 collaborators of Matias Autio. A scholar is included among the top collaborators of Matias Autio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matias Autio. Matias Autio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 4
2 1
3 2
4 0
5 7
6 2
7 2
8 1
9 71
10 35
11 14
12 8
13 96
14 3
15 35
16 1
17 0
18 45
19 1

About Matias Autio

Matias Autio is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology, having authored 19 papers that have together received 328 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (180 citations), Oncology (157 citations) and Cancer Research (70 citations). Matias Autio has collaborated with scholars based in Finland, Denmark and Norway. Frequent co-authors include Sirpa Leppä, Marja‐Liisa Karjalainen‐Lindsberg, Suvi‐Katri Leivonen, Teijo Pellinen, Oscar Brück, Satu Mustjoki, Harald Holte, Judit Jørgensen, Roger Foo and Esa Pitkänen. Their work appears in journals such as Circulation, Blood and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026